Chemical Structure (Braftovi 01)
Braftovi Capsule
Product Images NDC 70255-025
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Braftovi (NDC 70255-025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Array Biopharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Braftovi 02)
Principal Display Panel (75 mg Capsule Bottle Carton)
Not available.*
Principal Display Panel (50 mg Capsule Bottle Carton)
This is a medication guide for Encorafenib capsules containing 75mg each. The capsules are for oral consumption and should be stored in their original bottle between 15°C and 30°C. The medication should not be used if the safety seal is missing or broken. The container should be protected from moisture and kept tightly closed. The recommended dosage for Encorafenib should be reviewed from the prescribing information. The medication is for Rx use only and should be dispensed in the original bottle. This medication is distributed by Array BioPharma Inc., a subsidiary of Pfizer Inc. 90 Capsules are available in one bottle.*
Braftovi 05
The text is a medication guide for Braftovi capsules containing 75 mg of encorafenib. It is recommended to dispense in the original bottle and keep it protected from moisture. It should be stored at room temperature. It is distributed by Array BioPharma Inc. and only available by prescription.*
Braftovi 06
Each capsule contains 75 mg of encorafenib. The recommended dosage can be found in the prescribing information. Store at room temperature between 20°C and 25°C (68°F-T7°F) with excursions allowed from 15°C to 30°C (58°F and 86°F). Do not use if safety seal under cap is broken or missing. Dispense in the original bottle and do not remove the desiccant to protect from moisture. Keep the container tightly closed. This medication is distributed by Array BioPharma Inc., a subsidiary of Pfizer Inc. and made in France. A medication guide should be enclosed for each patient. The product is not for sale and is a sample with 60 capsules per bottle. The LOT/EXP number is not available.*
Braftovi 07
This is a medication guide for BRAFTOVI (encorafenib) capsules containing 75 mg of encorafenib. The recommended dosage needs to be seen in the prescribing information, and it should be stored at room temperature between 20°C-25°C (68°F-77°F). The container should be kept tightly closed, and it should be protected from moisture. It should not be dispensed if the safety seal under the cap is missing or broken. It is distributed by Array BioPharma Inc., a subsidiary of Pfizer Inc., and the product is made in France.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
